Lanka Hospitals’ Blood Cancer Centre celebrates its 7th anniversary

Lanka Hospitals reached another milestone recently when its Blood Cancer Centre that provides treatment for blood cancer and other blood disorders reached its seventh anniversary in October 2020.

Lanka Hospitals is the only private hospital with a dedicated Centre for blood cancer care, and offers treatment for Leukaemia, Lymphoma, Myeloma and bone marrow transplants. The dedicated centre, established in October 2013, is equipped with all the required medical and surgical facilities to diagnose and treat patients to the highest international medical standard.

“Our Blood Cancer Centre is the only facility which offers the services of a Resident Clinical Haematologist/Haemato-Oncologist in addition to visiting General Oncologists, Hematologists and Transfusion Consultants. Furthermore, we have specially trained nursing staff that specialize in the treatment of blood cancers and blood-related disorders. We are proud of our team’s achievements and thank them all for their contribution,” Lanka Hospitals’ Group Chief Executive Officer, Deepthi Lokuarachchi said.

“The Blood Cancer Centre has a dedicated in-patient, out-patient and day-care facility. We have maintained our services on a high standard similar to blood cancer treatment facilities in advanced countries. We thank all those who have visited the Blood Cancer Centre for placing their trust on our dedicated team,” Lanka Hospitals’ Director Medical Services, Dr. Wimal Karandagoda noted.

In November 2015, Lanka Hospital blood cancer Centre introduced a Multi-Disciplinary Team (MDT) meeting, a mechanism put forward for careful review and decision-making with regard to the treatment and diagnosis of patients with blood cancer and blood disorders.

“At these meetings, a range of experts of other varying specialties such as pathologists, radiologists, oncological surgeons and specialized nurses come together as a team to offer the best and most suitable form of treatment for each patient. We have cared for nearly 3,000 patients according to UK protocols and their response and survival parameters are on par with Western countries”, said Dr. Saman Hewamana, the Centre’s Clinical Haematologist/Haemato-Oncologist,

Lanka Hospitals’ Blood Cancer Centre also reached a milestone when it launched the Blood Cancer Care Fund in early 2019 to assist those who have blood cancer, by easing their financial burden of meeting the cost of treatment.

“We believe research is one of the key factors in improving patient outcomes. We undertake retrospective analysis to improve our understanding of blood cancers and the application of Western treatment protocols to Sri Lankan patients. We have proven to have maintained response rates and survival parameters comparable to data from other European centres”, Senior Consultant Oncologist, Dr. Jayantha Balawardena, said.

Lanka Hospitals Diagnostics (LHD) is the only Sri Lankan laboratory to be accredited by the prestigious laboratory accreditation body, The College of American Pathologists (CAP).